Current role of chemoembolization in the treatment of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) accounts for 75% to 85% of primary liver cancers. Recent years have shown a significant increase in the incidence of HCC in Europe and the United States.
Rafał Kidziński +2 more
doaj +1 more source
Semi-Quantitative Analysis of Post-Transarterial Radioembolization 90Y Microsphere Positron Emission Tomography Combined with Computed Tomography (PET/CT) Images in Advanced Liver Malignancy: Comparison With 99mTc Macroaggregated Albumin (MAA) Single Photon Emission Computed Tomography (SPECT) [PDF]
Seunghong Rhee +8 more
openalex +1 more source
Repeated Transarterial Radioembolization Adverse Event and Hepatotoxicity Profile in Cirrhotic Patients With Hepatocellular Carcinoma: A Single-Center Experience [PDF]
Dustin K Reed +5 more
openalex +1 more source
The evolving role of selective internal radiation therapy in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) remains a major global oncological burden, accounting for over 900,000 new diagnoses and more than 800,000 deaths each year.
Guido Faggian +7 more
doaj +1 more source
Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial [PDF]
core +1 more source

